Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Schett

Showing results (491-500 of 1,050) with videos related to

Pageof 105
Sort By:
Seminars in Arthritis and Rheumatism|January 9, 2016
Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemiaChristina Petsch, Elizabeth G Araujo, Matthias Englbrecht, et al.
Gut|January 20, 2016
IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivoKristina Scheibe, Ingo Backert, Stefan Wirtz, et al.
Seminars in Arthritis and Rheumatism|June 26, 2016
High prevalence of tenosynovial inflammation before onset of rheumatoid arthritis and its link to progression to RA-A combined MRI/CT studyArnd Kleyer, Manuel Krieter, Isabelle Oliveira, et al.
Acta Diabetologica|May 23, 2014
Relations of vitamin D status, gender and type 2 diabetes in middle-aged CaucasiansAndreas Stadlmayr, Elmar Aigner, Ursula Huber-Schönauer, et al.
Nature Communications|January 19, 2018
Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune diseaseXianyi Meng, Bettina Grötsch, Yubin Luo, et al.
The American Journal of Pathology|January 27, 2004
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritisKurt Redlich, Birgit Görtz, Silvia Hayer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2016
Quantification and Impact of Secondary Osteoarthritis in Patients With Anti-Citrullinated Protein Antibody-Positive Rheumatoid ArthritisCamille P Figueiredo, David Simon, Matthias Englbrecht, et al.
Annals of the Rheumatic Diseases|March 23, 2013
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodiesArnd Kleyer, Stephanie Finzel, Jürgen Rech, et al.
Arthritis Research & Therapy|July 28, 2019
Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA studyEleni Kampylafka, David Simon, Isabelle d'Oliveira, et al.
Arthritis Research & Therapy|February 12, 2017
Development of three-dimensional prints of arthritic joints for supporting patients' awareness to structural damageArnd Kleyer, Laura Beyer, Christoph Simon, et al.
Pageof 105

Showing results (491-500 of 1,050) with videos related to

Sort By:
Pageof 105
Seminars in Arthritis and Rheumatism|January 9, 2016
Prevalence of monosodium urate deposits in a population of rheumatoid arthritis patients with hyperuricemiaChristina Petsch, Elizabeth G Araujo, Matthias Englbrecht, et al.
Gut|January 20, 2016
IL-36R signalling activates intestinal epithelial cells and fibroblasts and promotes mucosal healing in vivoKristina Scheibe, Ingo Backert, Stefan Wirtz, et al.
Seminars in Arthritis and Rheumatism|June 26, 2016
High prevalence of tenosynovial inflammation before onset of rheumatoid arthritis and its link to progression to RA-A combined MRI/CT studyArnd Kleyer, Manuel Krieter, Isabelle Oliveira, et al.
Acta Diabetologica|May 23, 2014
Relations of vitamin D status, gender and type 2 diabetes in middle-aged CaucasiansAndreas Stadlmayr, Elmar Aigner, Ursula Huber-Schönauer, et al.
Nature Communications|January 19, 2018
Hypoxia-inducible factor-1α is a critical transcription factor for IL-10-producing B cells in autoimmune diseaseXianyi Meng, Bettina Grötsch, Yubin Luo, et al.
The American Journal of Pathology|January 27, 2004
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritisKurt Redlich, Birgit Görtz, Silvia Hayer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 10, 2016
Quantification and Impact of Secondary Osteoarthritis in Patients With Anti-Citrullinated Protein Antibody-Positive Rheumatoid ArthritisCamille P Figueiredo, David Simon, Matthias Englbrecht, et al.
Annals of the Rheumatic Diseases|March 23, 2013
Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodiesArnd Kleyer, Stephanie Finzel, Jürgen Rech, et al.
Arthritis Research & Therapy|July 28, 2019
Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA studyEleni Kampylafka, David Simon, Isabelle d'Oliveira, et al.
Arthritis Research & Therapy|February 12, 2017
Development of three-dimensional prints of arthritic joints for supporting patients' awareness to structural damageArnd Kleyer, Laura Beyer, Christoph Simon, et al.
Pageof 105